Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P11021 (
BiP
)
2,049
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Severe congenital neutropenia (SCN) and cyclic neutropenia (CyN) are sporadic or inherited hematologic disorders of myelopoiesis. Heterozygous mutations in the gene encoding
neutrophil elastase
(
ELA2
) have been reported in both diseases. We used an inducible system to express a panel of
ELA2
mutations and found for almost all mutants disruption of intracellular
neutrophil elastase
(HNE) protein processing at different levels. This disruption resulted in cytoplasmic accumulation of a nonfunctional protein, thereby preventing its physiologic transport to azurophil granules. Furthermore, the secretory capacity of the mutant proteins was greatly diminished, indicating alteration of the regulated and the constitutive pathways. Through analysis of primary granulocytes from SCN patients carrying
ELA2
mutations, we found an identical pattern of intracellular accumulation of mutant HNE protein in the cytoplasm. Moreover, cells expressing mutant HNE protein exhibited a significant increase in apoptosis associated with up-regulation of the master ER chaperone
BiP
, indicating that disturbance of intracellular trafficking results in activation of the mammalian unfolded protein response.
...
PMID:Mutations in neutrophil elastase causing congenital neutropenia lead to cytoplasmic protein accumulation and induction of the unfolded protein response. 1655 67
Severe congenital neutropenia (SCN) is an inborn disorder of granulopoiesis. Mutations of the
ELA2
gene encoding
neutrophil elastase
(NE) are responsible for most cases of SCN and cyclic neutropenia (CN), a related but milder disorder of granulopoiesis. However, the mechanisms by which these mutations disrupt granulopoiesis are unclear. We hypothesize that the
ELA2
mutations result in the production of misfolded NE protein, activation of the unfolded protein response (UPR), and ultimately apoptosis of granulocytic precursors. Expression of mutant NE but not wild-type NE strongly induced
BiP
/GRP78 mRNA expression and XBP1 mRNA splicing, 2 classic markers of the UPR. The magnitude of UPR activation by a specific
ELA2
mutation correlated with its associated clinical phenotype. Consistent with the UPR model, expression of mutant NE in primary human granulocytic precursors increased expression of CHOP (DDITS) and induced apoptosis in a protease-independent fashion. Most strikingly, UPR activation and decreased NE protein expression were detected in primary granulocytic precursors from SCN patients. Collectively, these data provide strong support for a UPR model of SCN disease pathogenesis and place SCN in a growing list of human diseases caused by misfolded proteins.
...
PMID:Mutations of the ELA2 gene found in patients with severe congenital neutropenia induce the unfolded protein response and cellular apoptosis. 1776 33
Deficiency in neutrophils (neutropenia) caused by mutations in
neutrophil elastase
(NE,
ELA2
) has been extensively investigated. Monocytes and neutrophils are derived from a common myeloid progenitor; therefore,
ELA2
mutations can also influence monocyte development. These effects have not been well described. In this study, we used the human monocytic THP-1, to carry the human wild-type and G185R mutant
ELA2
gene. Growth, death, differentiation and
BiP
expression were evaluated in the two stable cell lines and in the wild-type THP-1 cells. Exogenous wild-type
ELA2
markedly increased THP-1 differentiation, whereas G185R
ELA2
was incompetent to promote THP-1 differentiation in response to all-trans retinoic acid (ATRA). Indeed, during differentiation induced by ATRA, G185R cell line showed significant cell death. Also, up-regulated
BiP
expression accompanied cell death in the G185R cells, suggesting that the overexpression of G185R elastase increases apoptosis through an unfolded protein response. The G185R cells treated with lithium chloride (LiCl; a Wnt signalling activator) displayed higher
BiP
expression but similar cell viability compared with THP1 and HNEwt/THP1 cells treated with LiCl. This suggested that Wnt signalling might increase cellular tolerance to endoplasmic reticulum stress, enabling mutant monocyte survival.
...
PMID:The neutrophil elastase mutant affects viability and differentiation of the human monocytic THP-1 cell. 2299 20